45th week of 2009 patent applcation highlights part 39 |
Patent application number | Title | Published |
20090275708 | Thermosetting Epoxy Resin Composition - Even when a terminal epoxy resin is contained as the epoxy component of a thermosetting epoxy resin composition containing an aluminum chelate/silanol curing catalyst system, the epoxy resin composition can be configured to cure rapidly at low temperatures without termination of polymerization. | 2009-11-05 |
20090275709 | PHASE BOUNDARY PROCESSES FOR PREPARING POLYCARBONATES - Continuous processes for preparing polycarbonates having a weight average molecular weight M | 2009-11-05 |
20090275710 | Methods of preparing a polymerization catalyst - A method comprising contacting a support with a chromium-containing compound and a tin-containing compound to produce a catalyst precursor, and activating the catalyst precursor in a temperature range of from about 400° C. to about 700° C. to produce a polymerization catalyst. A method comprising contacting a support with a chromium-containing compound and a tin-containing compound to produce a catalyst precursor, activating the catalyst precursor in a temperature range of from about 400° C. to about 700° C. to produce a polymerization catalyst, and contacting the polymerization catalyst with ethylene in a reaction zone under suitable reaction conditions to form polyethylene wherein the molecular weight distribution of the polyethylene is broadened. | 2009-11-05 |
20090275711 | Olefin polymerization process - A slurry process for polymerizing ethylene is disclosed. The process comprises polymerizing ethylene in a first reactor in the presence of hydrogen and a catalyst comprising an activator and a supported dimethylsilyl-bridged indeno[1,2-b]indolyl zirconium complex to produce an ethylene homopolymer, removing some of the unreacted hydrogen, and reacting the homopolymer slurry in a second reactor with ethylene and a C | 2009-11-05 |
20090275712 | Metallocene Compounds - A bridged metallocene compound of formula (I) | 2009-11-05 |
20090275713 | Method for promoting Michael addition reactions - Homogeneously dispersed solid reaction promoters having an average particle size from 0.01 μm to 500 μm are disclosed for preparing curable mixtures of at least one Michael donor and at least one Michael acceptor. The resulting curable mixtures are useful as coatings, adhesives, sealants and elastomers. | 2009-11-05 |
20090275714 | New Ruthenium Complexes as Catalysts for Metathesis Reactions - The invention relates to novel metathesis catalysts of the formula | 2009-11-05 |
20090275715 | High Modulus Bio-Based Polymer Formulations - The present invention is a high modulus bio-based plastic or polymer composition and methods of using the same. The composition is formed from the reaction of a bio-based epoxidized unsaturated triglyceride, an energy activated catalyst and a bio-based non-aromatic bio-based cross-linking compound to form a structural polymer plastic. | 2009-11-05 |
20090275716 | Branched Ionomers - A branched aromatic ionomer is prepared by co-polymerizing a first monomer having an aromatic moiety and an unsaturated alkyl moiety and a second monomer having an ionic moiety and at least one unsaturated moiety. The ionic moiety may have a cationic group having a valence of +1 or greater. Styrene is among the useful first monomers and sodium methacrylate and zinc dimethacrylate are among the useful second monomers. The branched aromatic ionomers may be used to prepare articles including foamed polystyrene and microwave save dishes and utensils. | 2009-11-05 |
20090275717 | Polymerizable water-soluble or alcohol-soluble ultraviolet absorber - The present invention relates to a polymerizable water-soluble or alcohol-soluble ultraviolet absorber, which is represented by the following formula (I): | 2009-11-05 |
20090275718 | Resin composition and optical films formed by using the same - The present invention relates to a transparent resin composition which comprises (a) a (meth)acrylate based unit comprising one or more (meth)acrylate based derivatives; (b) an aromatic based unit having a chain having the hydroxy group containing portion and an aromatic moiety and (c) a styrene-based unit comprising one or more styrene-based derivatives, and an optical film that is formed by using the same. | 2009-11-05 |
20090275719 | Film Comprising Norbornene Compound Addition Polymer - [Problems] To provide a film comprising a norbornene (NB) compound addition polymer that is excellent in chemical resistance, optical properties and the like, has a high Tg, a low water absorption ratio and a low linear expansion coefficient, and is soluble in an ordinary solvent. | 2009-11-05 |
20090275720 | ORTHO-BENZYLPHENOL MONO(METH)ACRYLATE MONOMERS SUITABLE FOR MICROSTRUCTURED OPTICAL FILMS - Optical films having a polymerized microstructured surface and polymerizable resin compositions are described comprising at least one ortho-benzylphenol mono(meth)acrylate monomer. | 2009-11-05 |
20090275721 | Coating Surfaces - Disclosed is a method of attaching, indirectly, a member of a specific binding pair (or sbp) to a surface, the method comprising the steps of: (a) contacting the surface with a solution, preferably an aqueous solution, of a polymer, having side chains according to the formula X-Y-Z-R, wherein X is a spacer group; Y is a sulphur, selenium or tellurium atom; Z is a sulphur, selenium or tellurium atom, any of which may be bonded to one or two oxygen atoms; and wherein R is any suitable moiety such that -Z-R constitutes a leaving group; such that at least some of the -Z-R groups are displaced and the polymer becomes bound to the surface by X-Y groups; and (b) contacting a polymer-coated surface resulting from step (a) with a solution, preferably an aqueous solution, comprising an sbp member, so as to cause the polymer to react with the sbp member, so as to attach the sbp member, indirectly, to the surface. | 2009-11-05 |
20090275722 | AUTOMIXABLE PUTTY IMPRESSION MATERIAL - The present invention relates to a multicomponent automixable putty impression material, its components, mixtures of the components and a method for obtaining impressions with the multicomponent automixable putty impression material. | 2009-11-05 |
20090275723 | PROCESSES FOR MAKING STABILIZED DIVALENT GERMANIUM AND TIN COMPOUNDS - Processes for making ivalent germanium and tin compounds are provided. The divalent germanium and tin compounds have been found to be efficient catalysts for the formation of polyurethanes. | 2009-11-05 |
20090275724 | IONIC LIQUIDS IN THE PREPARATION OF POMS - Process for preparing polyoxymethylenes by polymerization of the monomers a) in the presence of cationically active initiators b) and, if appropriate in the presence of regulators c) and subsequent deactivation d) and discharge from the reactor, wherein at least one ionic liquid is used as initiator b). | 2009-11-05 |
20090275725 | POLYSULPHONES AND POLYETHER SULPHONES WITH REDUCED YELLOW INDEX AND PROCESSES FOR THEIR PREPARATION - The present invention relates to a process for the preparation of polysulfones having a yellowness index according to DIN 6167 of less than 19 and polyether sulfones having a yellowness index according to DIN 6167 of less than 30, wherein the polymerization is carried out in basic, aprotic solvents with the use of a positively conveying stirrer passing close to the wall. The present invention also relates to the polyether sulfones and polysulfones obtainable for the first time by this process and to the use of such polymers for the production of moldings, films, membranes and foams. | 2009-11-05 |
20090275726 | PROCESS FOR PRODUCING EPICHLOROHYDRIN - Process for producing epichlorohydrin comprising subjecting to a dehydrochlorination operation, dichloropropanol produced from glycerol comprising aldehydes. | 2009-11-05 |
20090275727 | Peptide turn mimetics - This invention provides novel compounds useful for the synthesis of peptide mimetics, and describes the use of these compounds for the synthesis of novel reverse turn mimetics. The reverse turn mimetics of the invention have the general structure X wherein the variables are as defined herein. | 2009-11-05 |
20090275728 | COMPOUND HAVING HISTONE DEACETYLASE-INHIBITING ACTIVITY, AND PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUND AS AN ACTIVE INGREDIENT - A novel compound having histone deacetylase-inhibiting activity which is a cyclic tetrapeptide derivative represented by the general formula (1) given below and a pharmaceutical composition comprising such compound as an active ingredient. (In the formula, the cyclic tetrapeptide moiety has a known structure; R | 2009-11-05 |
20090275729 | MICRORNA AND METHODS FOR INHIBITING SAME - The invention relates to isolated DNA or RNA molecules comprising at least ten contiguous bases having a sequence in a pancreatic islet microRNA. In another embodiment, the invention relates to isolated single stranded pancreatic islet microRNA molecules or anti-pancreatic islet microRNA molecules. | 2009-11-05 |
20090275730 | Temperature responsive depsipeptide polymer - There is provided a temperature responsive polymer compound which comprises a repeating unit represented by the following general formula (I): | 2009-11-05 |
20090275731 | METHOD FOR PRODUCING PROTEIN - It has been required to refold an inactive protein into an active protein with high efficacy. This problem can be solved by the method for producing a protein including a step of providing a porous body supporting an inactive protein in its mesopores, a step of applying a denaturant to the porous body supporting the inactive protein, and a step of changing the inactive protein to an active protein by removing the denaturant from the porous body. | 2009-11-05 |
20090275732 | Agent for improving circulatory disorder - Provided is a pharmaceutical agent capable of efficiently improving blood circulation in a region where a circulatory disorder occurs and fully preventing or improving tissue damage as a preventive or therapeutic agent for circulatory disorders in general. As a result of the study of pharmacological effects of a compound in which a porphyrin metal complex is clathrated in albumin, it was found that the compound efficiently improves decreases in blood flow in circulatory disorders and fully prevents or improves tissue damage, thus the invention was achieved. That is, the invention is directed to an agent for improving a circulatory disorder including a compound in which a porphyrin metal complex is clathrated in albumin. | 2009-11-05 |
20090275733 | Production of mustard seed protein isolate - Mustard seed protein isolates are produced at a high purity level of at least about 100 wt % (N×6.25) by a process wherein mustard seed protein is extracted from mustard seed meal, the resulting aqueous mustard seed protein solution is concentrated to a mustard seed protein content of at least about 200 g/L, and the concentrated mustard seed protein solution is added to chilled water having a temperature below about 15° C. to form mustard seed protein micelles, which are settled to provide a mustard seed protein micellar mass (PMM). The mustard seed protein micellar mass is separated from supernatant and may be dried. | 2009-11-05 |
20090275734 | Pancreatic Cancer Genes - The present invention provides the art with the DNA coding sequences of polynucleotides that are up-or-down-regulated in cancer and dysplasia. These polynucleotides and encoded proteins or polypeptides can be used in the diagnosis or identification of cancer and dysplasia. Inhibitors of the up-regulated polynucleotides and proteins can decrease the abnormality of cancer and dysplasia. Enhancing the expression of down-regulated polynucleotides or introducing down-regulated proteins to cells can decrease the growth and/or abnormal characteristics of cancer and dysplasia. | 2009-11-05 |
20090275735 | MONOCLONAL ANTIBODIES TO HUMAN CTLA-8 (IL-17A) - Human CTLA-8 protein, antibodies that specifically bind to human CTLA-8, and nucleic acids encoding human CTLA-8. Methods of using these molecules and diagnostic kits are also provided. | 2009-11-05 |
20090275736 | NMDAR Biomarkers for Diagnosis and Treatment of Traumatic Brain Injury and Other Disorders - Provided are methods for detecting various subunits and isoforms of NMDA receptors to help diagnose and differentiate (1) the anatomical location of NMDA receptor over-expression, (2) ischemic conditions in the central and peripheral nervous systems, and (3) the type and cause of chronic pain. | 2009-11-05 |
20090275737 | IMMUNOGENIC COMPOSITIONS AND USES THEREOF - The present invention relates generally to a method of eliciting or otherwise inducing an effective immune response to a micro-organism and compositions for use therein. More particularly, the present invention relates to a method of inducing an immune response to a parasite utilising an immunogenic composition comprising a glycosylphosphatidylinositol (referred to herein as “GPIt”) inositolglycan domain or its derivatives. Even more particularly, the present invention contemplates an immunogenic composition comprising the | 2009-11-05 |
20090275738 | Use of A33 antigens and jam-it - The present invention relates to compositions and methods of treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer. | 2009-11-05 |
20090275739 | Purification of Glycopeptides - A novel and improved method for purification of glycopeptides, especially glycopeptide antibiotics. The method comprises contacting a solution of the glycopeptide to an ion exchange chromatography material. The product of this method has a surprisingly high purity. | 2009-11-05 |
20090275740 | NOVEL COLLECTIN - Provided are isolated collectin (CL-L2s) genes including a base sequence set out in SEQ ID NO: 1, 3, 5, 7, 9, 12, 36, 38 or 40 relating to a novel collectin which are expected to exhibit an antibacterial activity, an antiviral activity and the like particularly in a human body; and isolated collectin proteins including an amino acid sequence set out in SEQ ID NO: 2, 4, 6, 8, 10, 13, 37, 39 or 41 and derivatives and fragments thereof. | 2009-11-05 |
20090275741 | PLANTS AND SEEDS OF CORN VARIETY CV678981 - According to the invention, there is provided seed and plants of the corn variety designated CV678981. The invention thus relates to the plants, seeds and tissue cultures of the variety CV678981, and to methods for producing a corn plant produced by crossing a corn plant of variety CV678981 with itself or with another corn plant, such as a plant of another variety. The invention further relates to corn seeds and plants produced by crossing plants of variety CV678981 with plants of another variety, such as another inbred line. The invention further relates to the inbred and hybrid genetic complements of plants of variety CV678981. | 2009-11-05 |
20090275742 | COLORING MATTER FOR ANISOTROPIC COLORING MATTER FILM, COMPOSITION COMPRISING SAID COLORING MATTER, ANISOTROPIC COLORING MATTER FILM, AND POLARIZING ELEMENT - It is to provide a dye for an anisotropic dye film to be formed by a wet system film-forming method, which is achromatic and has high dichroism and a high degree of molecular orientation, an anisotropic dye film containing the dye and a polarizing element employing the film. | 2009-11-05 |
20090275743 | METHOD OF PREPARING CARRIER TO SEPARATE NUCLEIC ACIDS, CARRIER AND MICRO CHANNEL TO SEPARATE NUCLEIC ACIDS, AND METHOD AND APPARATUS FOR SEPARATING NUCLEIC ACIDS - The present invention provides a method for producing a carrier for nucleic acid separation, the method including a step of: immobilizing capturing chains onto a porous carrier having cation-exchangeable groups thereon by ion exchange bonding, the capturing chains having a base sequence complementary to target nucleic acid chains and being modified with functional groups having positive charges. | 2009-11-05 |
20090275744 | PRODUCTION OF SUGAR ESTERS FROM VINYL FATTY ACID ESTERS - A sugar ester product is manufactured from sugar and vinyl fatty acid. Sugar is first dissolved in dimethyl sulfoxide with a metal carbonate catalyst. A vinyl fatty acid ester is added to the sugar mixture; a sugar ester product and acetaldehyde are formed. Vacuum can be used to remove acetaldehyde to drive the reaction towards completion. Depending on the sugar to vinyl fatty acid ester ratio, one can obtain a reaction yield greater than 90% with a monoester content of 90%. DMSO is then recovered by vacuum distillation. The crude product is dissolved in brine; sucrose stearate along with vinyl stearate and traces of sucrose are extracted by adding isobutanol. The isobutanol phase is separated from the aqueous phase and concentrated. Spray drying steps are carried out to remove residual solvents and vinyl stearate. The product is a white powder that meets FDA specifications for sucrose esters. | 2009-11-05 |
20090275745 | CHITOSAN MANUFACTURING PROCESS - A method for producing chitosan from naturally occurring chitin-containing raw material, such as crustacean shells, includes an optional pretreatment step to remove non-chitin rich organic material for example, shrimp flesh, from the raw material, e.g., shrimp shells. The optional pretreatment is followed by a demineralization step utilizing a mild hydrochloric acid solution and a deproteination step utilizing a mild sodium hydroxide solution. The deproteination step is followed by a deacetylation step to remove the acetyl group from N-acetylglucosamine (chitin) to form an amine group, yielding d-glucosamine (chitosan). Each step is followed by a washing step and the product is dried, preferably at a temperature not in excess of about 65° C. Known purification and grinding steps may also be used to produce the final chitosan product. The process is carried out in equipment comprising a series of substantially identical or similar tanks ( | 2009-11-05 |
20090275746 | SOLID FAROPENEM FREE ACID - The present invention provides solid form of faropenem free acid, its hydrates and processes for their preparation thereof. Thus, for example, dissolving an alkali metal salt of faropenem in water, adjusting the pH of the solution formed with an acid to below about 2.5 and collecting the precipitated solid to obtain solid faropenem free acid. | 2009-11-05 |
20090275747 | METHODS FOR THE PREPARATION OF SALTS OF 2-[2-(4-DIBENZO[B,F][1,4]THIAZEPIN-11-YL-1-PIPERAZINYL)ETHOXYL]ETHANOL (QUETIAPINE) AND FOR THE PURIFICATION THEREOF - A method for the preparation of salts of 2-[2-(4-dibenzo[b,fj[1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol (quetiapine) from the quetiapine base and the respective acid, wherein the salt is precipitated from a mixture of solvents, the mixture being either a mixture of an aromatic hydrocarbon and a ketone or ester, or that of an aromatic hydrocarbon, water and a ketone or ester. The salts of quetiapine are purified by partial crystallization, wherein only a part of the salt of quetiapine is dissolved in a C | 2009-11-05 |
20090275748 | Benzoimidazole compounds - Benzoimidazole compounds, compositions, and methods of using them in leukocyte recruitment inhibition, in modulating H | 2009-11-05 |
20090275749 | PRODUCTION METHOD OF OPTICALLY ACTIVE PIPERAZINE COMPOUND - Provided is a method of producing optically active 1-methyl-3-phenylpiperazine of the formula (11) or salt thereof, comprising the following steps 1 to 4, or steps 5 to 7 and step 4, and a method of producing optically active mirtazapine via this method. | 2009-11-05 |
20090275750 | DIPEPTIDYL PEPTIDASE INHIBITORS - Methods of making compounds of the formula (I) wherein the variables are as defined herein. Also, methods of making compounds that may be used to inhibit dipeptidyl peptidase. | 2009-11-05 |
20090275751 | 1,2-DIHYDROPYRIDINE COMPOUNDS, MANUFACTURING METHOD THEREOF AND USE THEREOF - The present invention provides a novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. | 2009-11-05 |
20090275752 | Novel Process for Statins and its Pharmaceutically Acceptable Salts Thereof - Novel process for statins and its pharmaceutically acceptable salts thereof represented by general formula (I). | 2009-11-05 |
20090275753 | ORTHO-SUBSTITUTED ANILINE DERIVATIVE AND ANTIOXIDANT DRUG - A compound represented by formula (1) or a salt thereof, and an antioxidant drug containing the compound or the salt as an active ingredient, are provided. The compound or salt exhibits effective antioxidant activity in treating ischemic organ disorders and diseases caused by oxidative cell damage, and in inhibiting retinal lesions caused by oxidation due to the effects of light. | 2009-11-05 |
20090275754 | Narcotine Purification Process - A process for purifying Narcotine to remove color and impurities to form Noscapine. The process includes forming an aqueous isopropanol solution with the Narcotine product wherein the isopropanol concentration of the solution is about 20% to about 70% by volume; and adjusting the pH of the solution with a strong base to a pH of about 10 to about 14, wherein impurities are removed from the Narcotine product. | 2009-11-05 |
20090275755 | Process for the Preparation of S-(+)-Clopidogrel by Optical Resolution - The present invention relates to a process for the preparation of S-(+)-clopidogrel by an optical resolution and, more particularly, to a process for the preparation of S-(+)-clopidogrel represented by the following formula 1 with high optical purity by converting a clopidogrel racemic carboxylic acid into a diastereomeric salt using a (+)-cinchonine for optical resolution, extracting an S-(+)-clopidogrel carboxylic acid from the diastereomeric salt using a suitable solvent under an acidic condition and then reacting the S-(+)-clopidogrel carboxylic acid with methanol. | 2009-11-05 |
20090275756 | 2-OXETANONE DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF - An aldehyde derivative represented by the general formula ( | 2009-11-05 |
20090275757 | NOVEL CRYSTAL OF 3-[5-[4-(CYCLOPENTYLOXY)-2- HYDROXYBENZOYL]-2-[(3-HYDROXY-1,2-BENZISOXAZOL-6- YL)METHOXY]PHENYL]PROPIONIC ACID - The crystal of 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propionic acid having peaks at the position of 14.0, 16.0, 23.3, 23.7 and 26.3° and the crystal of 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propionic acid having peaks at the position of 14.6, 23.1, 24.7, 25.6 and 26.0° on 2θ of diffraction angle in a powder X-ray diffraction pattern have a small specific volume, are hard to be charged with electricity, are easily handled and are useful for an active pharmaceutical ingredient of excellent anti-rheumatic agents. | 2009-11-05 |
20090275758 | PROCESS FOR PHENYLACETIC ACID DERIVATIVES - A process for the production of a compound of Formula I, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable prodrug ester thereof, | 2009-11-05 |
20090275759 | PROCESS FOR PREPARING DORZOLAMIDE - A process for resolving dorzolamide trans racemate, which comprises reacting said racemate with (1S)-(+)-10-camphorsulfonic acid so obtaining the (4S,6S) enantiomer by selectively precipitating and recovering the camphorsulfonic acid salt thereof (dorzolamide camphorsulfonate), and neutralizing dorzolamide camphorsulfonate to obtain dorzolamide. | 2009-11-05 |
20090275760 | PROCESS FOR THE PREPARATION OF PURE DULOXETINE HYDROCHLORIDE - The present invention relates to a process for the preparation of pure Duloxetine hydrochloride. The present invention further relates to duloxetine hydrochloride substantially free of residual hydrochloric acid. | 2009-11-05 |
20090275761 | Catalytic Preparation of Cyclic Carboxylic Esters - Preparation of cyclic esters by hydrogenation of a carbonyl group in at least one anhydride radical —C(O)—O—C(O)— of a cyclic dicarboxylic or polycarboxylic anhydride by means of hydrogen in the presence of a homogeneous noble metal catalyst, characterized in that the hydrogenation is carried out in a homogeneous reaction mixture using an iridium catalyst. The cyclic esters are obtained in good chemical and optical yields when prochiral anhydrides are used together with chiral iridium catalysts. | 2009-11-05 |
20090275762 | Crystalline Forms of Docetaxel and process for Preparation Thereof - New anhydrous crystalline form of docetaxel and process of making anhydrous docetaxel and docetaxel trihydrate are provided. | 2009-11-05 |
20090275763 | CATALYSTS HAVING ENHANCED STABILITY, EFFICIENCY AND/OR ACTIVITY FOR ALKYLENE OXIDE PRODUCTION - A catalyst for the manufacture of alkylene oxide, for example ethylene oxide, by the vapor-phase epoxidation of alkene containing impregnated silver and at least one efficiency-enhancing promoter on an inert, refractory solid support, said support incorporating a sufficient amount of zirconium component (present and remaining substantially as zirconium silicate) as to enhance at least one of catalyst activity, efficiency and stability as compared to a similar catalyst which does not contain the zirconium component. | 2009-11-05 |
20090275764 | OLEFIN EPOXIDATION PROCESS, A CATALYST FOR USE IN THE PROCESS, A CARRIER FOR USE IN PREPARING THE CATALYST, AND A PROCESS FOR PREPARING THE CARRIER - A process is provided for preparing a carrier which process comprises incorporating into the carrier at any stage of the carrier preparation a strength-enhancing additive. Also provided is the resultant carrier having incorporated therein a strength-enhancing additive and a catalyst comprising the carrier. Also provided is a process for the epoxidation of an olefin employing the catalyst. Also provided is a method of using the olefin oxide so produced for making a 1,2-diol, a 1,2-diol ether or an alkanolamine. | 2009-11-05 |
20090275765 | 2-Nitratoethyl Oxirane, Poly (2-Nitratoethyl Oxirane) And Preparation Method Thereof - A synthesis of an energetic prepolymer used as a high-energy binder for an insensitive and high performance explosive is disclosed. More specifically, provided are a novel compound 2-nitratoethyl oxirane expressed by formula III, a novel compound poly(2-nitratoethyl oxirane) expressed by formula IV, obtained by polymerization of 2-nitratoethyl oxirane used as a monomer and a preparation method thereof. The compound, used as an energetic prepolymer and a monomer for preparation thereof can substitute for existing poly(glycidyl nitrate) (PGN) which has been known to be a promising one having the best performance among existing energetic prepolymers, but which has a problem to be self-decomposed after synthesis of polyurethane elastomer, to solve this problem. | 2009-11-05 |
20090275766 | PROCESS FOR THE PREPARATION OF TIGECYCLINE IN THE AMORPHOUS FORM - The invention relates to processes for the preparation of tigecycline (I): | 2009-11-05 |
20090275767 | PROCESS FOR SYNTHESIS OF ANDROSTANE 17-BETA CARBOTHIOIC ACID AND RELATIVE COMPOUNDS THEREOF - A process for synthesis of androstane 17-β carbothioic acid is provided. The process includes mixing an androstane 17-β carboxylic acid and a coupling reagent, and adding an alkanethioic acid to form an androstane 17-β carbothioic acid, wherein the androstane 17-β carbothioic acid has the formula (I): | 2009-11-05 |
20090275768 | Preparation of Paricalcitol - This invention relates to a method for purifying Paricalcitol by reverse phase chromatography. This invention also relates to a purified Paricalcitol prepared by said method. This invention further relates to a method for purifying Paricalcitol by crystallization. | 2009-11-05 |
20090275769 | Method for esterification of fatty acids in glyceryl esters in a tubular reactor - A continuous process for esterification of fatty acids in glyceryl esters with C | 2009-11-05 |
20090275770 | NOVEL TIN AMINO-ALKOXIDE COMPLEXES AND PROCESS FOR PREPARING THEREOF - The present invention relates to novel tin amino-alkoxide complexes and a method for preparing the same, precisely novel tin amino-alkoxide complexes represented by formula 1 and useful as a precursor for tin and tin oxide thin films and a precursor for the production of nano-sized tin and tin oxide particles and a method for preparing the same. In formula 1, A is linear or branched (C2-C10) alkylene substituted or not substituted with halogen; R | 2009-11-05 |
20090275771 | Process for the preparation of urethanes - Urethanes are prepared by oxidative carbonylation of at least one amino compound in the presence of carbon monoxide, oxygen and organic, at least one hydroxyl-group-carrying compound. The carbonylation is carried out in the absence of halogen-containing promoters. The carbonylation is also carried out in the presence of a metal complex catalyst which contains neutral bidentate N-chelate ligands of the (N˜N) type, two monoanionic N,O-chelate ligands of the general type (N˜O) | 2009-11-05 |
20090275772 | Metrod for Producing 1,2-Phenylethane Compound Using Atom Transfer Radical Coupling Reaction - An object of the present invention is to provide a method capable of producing a 1,2-phenylethane compound with extremely high yield in a short amount of time. Disclosed is a method for producing a 1,2-phenylethane compound, which comprises subjecting a compound represented by formula (I): | 2009-11-05 |
20090275773 | PROCESS FOR THE TRANSESTERIFICATION OF TRIGLYCERIDES - The present invention relates to a process in which a triglyceride is transesterified with an alcohol in the presence of a solid catalyst. In order to provide a process by means of which a triglyceride can be transesterified with an alcohol in the presence of a solid catalyst in relatively moderate reaction conditions with a good yield and at relatively high reaction rate, it is proposed that the solid catalyst comprises a zeolite X with an Si/Al atomic ratio of less than 1.2. | 2009-11-05 |
20090275774 | Process for the Preparation of Carboxylic Acids and/or Derivatives Thereof - Preparation Of C1-C6 aliphatic carboxylic acids and/or esters or anhydrides thereof by reacting an alcohol and/or reactive derivative thereof with carbon monoxide under hydrous conditions in the presence of a ferrierite catalyst. | 2009-11-05 |
20090275775 | METHOD FOR PRODUCING ISOCYANATES - The invention relates to a multistage process for the continuous preparation of organic, distillable isocyanates, preferably diisocyanates, particularly preferably aliphatic or cycloaliphatic diisocyanates, by reaction of the corresponding organic amines with urea and alcohols to liberate ammonia and form low molecular weight monomeric urethanes and thermal dissociation of the latter, in which by-products formed are at least partly utilized. | 2009-11-05 |
20090275776 | PROCESS AND EQUIPMENT FOR THE DECOMPOSITION AND RECOVERY OF ISOCYANATE COMPOUNDS - The present invention relates to a method for decomposing and recovering an isocyanate compound, which comprises: continuously mixing and dispersing into water at high pressure and high temperature an isocyanate compound having at least one isocyanate group or group derived from an isocyanate group in a molten state or solution state, supplying a liquid mixture containing the isocyanate compound and the water at high pressure and high temperature continuously to a reactor, followed by subjecting the isocyanate compound to a decomposition reaction in the reactor, and recovering a raw material for the isocyanate compound or a derivative thereof; and an apparatus for decomposing and recovering an isocyanate compound, which comprises: a reactor which brings water at high pressure and high temperature into contact with an isocyanate compound having at least one isocyanate group or group derived from an isocyanate group to cause a decomposition reaction, a water supply line which continuously supplies the water at high pressure and high temperature to a reactor, a compound supply line which continuously supplies the isocyanate compound in a molten state or solution state to the water supply line, an on-off valve which communicates the compound supply line with a vicinity of a communication portion of the water supply line to the reactor, a dehydrating device which conducts a dehydration of a decomposition reaction product discharged from the reactor, and a purification device which purifies the decomposition reaction product after the dehydration. | 2009-11-05 |
20090275777 | Carboxylic Acid Production Process Employing Solvent from Esterification of Lignocellulosic Material - Methods and apparatus for producing a carboxylic acid employing a solvent from esterification of lignocellulosic materials. An acid-containing composition from esterification of lignocellulosic materials can be employed in the oxidation of para-xylene to terephthalic acid. The acid-containing composition can comprise acetic acid, acetic anhydride, and one or more terpenes. | 2009-11-05 |
20090275778 | Process for preparing high purity corosolic acid and high purity ursolic acid - According to the present invention, there is provided a process for preparing corosolic acid comprising the steps of (1) dissolving crude extract of Japanese loquat leaves in alkali and aqueous alcohol and (2) applying the solution to a nonpolar adsorption resin to obtain corosolic acid. | 2009-11-05 |
20090275779 | METHOD FOR PRODUCING OPTICALLY ACTIVE BENZYLAMINE DERIVATIVE - The present invention relates to a method for producing an optically active benzylamine derivative which is useful as an intermediate for pharmaceutical products and the like. In the present invention, an optically active benzylalcohol derivative is reacted with a sulfonylamide derivative in the presence of a phosphine derivative and an azodicarbonyl compound, to obtain an optically active benzylsulfonylamide derivative as a novel compound. Then, the thus-obtained optically active benzylsulfonylamide derivative is reacted with a thiol derivative, thereby producing an optically active benzylamine derivative. According to the present invention, the compound can be easily produced by a simple and short process without racemization. | 2009-11-05 |
20090275780 | PROCESS FOR CONTROLLING THE PARTICLE SIZE OF A 3-(TRIFLUOROMETHYL)PHENYL]-1-AMINOPROPANE DERIVATIVE - The invention relates to a process for tightly controlling the particle size of cinacalcet hydrochloride, i.e. a process for preparing large or small crystals of cinacalcet hydrochloride, which yields cinacalcet hydrochloride in a narrow, reproducible and consistent distribution of particles, which hence does not require to reprocess, rework or destroy material of undesired size, which is efficient and cost-effective, and which is suitable for industrial implementation. | 2009-11-05 |
20090275781 | METHOD FOR PRODUCING AN AMINE - Processes comprising: (i) providing a reactant selected from the group consisting of primary alcohols, secondary alcohols, aldehydes, ketones and mixtures thereof, and (ii) reacting the reactant with hydrogen and a nitrogen compound selected from the group consisting of ammonia, primary amines, secondary amines and mixtures thereof, in the presence of a catalyst comprising a zirconium dioxide- and nickel-containing catalytically active composition, to form an amine; wherein the catalytically active composition, prior to reduction with hydrogen, comprises oxygen compounds of zirconium, copper, nickel and cobalt, and one or more oxygen compounds of molybdenum in an amount of 5.5 to 12% by weight, calculated as MoO | 2009-11-05 |
20090275782 | Quantum Dots Tailored with Electronically-Active Polymers - Cadmium selenide, and other quantum dot materials, can be integrated into thin films of poly(para-phenylene vinylene) (PPV) or other polymer compounds without aggregation of the nanocrystals. Solid-state photoluminescence spectra of composite materials prepared by these novel techniques reveal the effect of this greatly enhanced quantum dot-polymer interface relative to cases where the nanoparticles are aggregated, such that electronic communication and energy transfer between the nanoparticle and polymer components is made more efficient. | 2009-11-05 |
20090275783 | METHODS FOR PRODUCING OXIDIZED CYCLIC PHENOL SULFIDES - A method for producing an oxidized cyclic phenol sulfide which comprises the step of oxidizing a cyclic phenol sulfide of the following formula (1) as a raw material: | 2009-11-05 |
20090275784 | PROCESS FOR PRODUCING POLYGLYCERYL ETHER DERIVATIVE - The present invention relates to a process for producing polyglyceryl ether derivatives by reacting an alcohol with glycidol in the presence of a simple metal salt of rare earth element as a catalyst which is capable of realizing a highly-selective addition reaction of the alcohol and glycidol, and enhancing a conversion rate of the alcohol. | 2009-11-05 |
20090275785 | Distillation Method For The Purification Of Sevoflurane And The Maintenance Of Certain Equipment That May Be Used In The Distillation Process - Processes for preparing commercial quantities of a stable, pharmaceutically acceptable sevoflurane substantially tree of impurities are claimed. In another embodiment, a process for removing reactive metal, salts from the surface of metallic equipment used in the distillation of sevoflurane and rendering a non-inert metallic surface of the metallic equipment inert. | 2009-11-05 |
20090275786 | PROCESS FOR PRODUCING GLYCERYL ETHER - A method for producing a glyceryl ether, including the steps of feeding a compound represented by the general formula (I): | 2009-11-05 |
20090275787 | Alcohol Production Process - The invention relates to methods for the production of alcohols by microbial fermentation, particularly microbial fermentation of substrates comprising glycerol and/or acetate, to butanol. | 2009-11-05 |
20090275788 | Hydrogenation Processes Using Functional Surface Catalyst Composition - Hydrogenation processes using a catalyst composition which, preferably comprises a glass substrate, with one or more functional surface active constituents integrated on and/or in the substrate surface. A substantially nonporous substrate has (i) a total surface area between about 0.01 m | 2009-11-05 |
20090275789 | Treatment Of Small Pore Molecular Sieves And Their Use In The Conversion Of Oxygenates To Olefins - A method is disclosed of treating a porous crystalline molecular sieve having a pore size less than or equal to about 5 Angstroms to decrease its coke selectivity in oxygenate to olefin conversion reactions. The method comprises contacting the molecular sieve with an acid having a kinetic diameter greater than or equal to that of acetic acid. | 2009-11-05 |
20090275790 | SYNTHESIS OF SAPO-34 WITH ESSENTIALLY PURE CHA FRAMEWORK - A process for producing an ElAPO molecular sieve with essentially pure CHA framework is disclosed. When El is silicon the process allows for a broad range of silicon content, and produces a catalyst with a high selectivity for the conversion of methanol to olefins. | 2009-11-05 |
20090275791 | CERAMIC FOAM CATALYST SUPPORT FOR GASOLINE ALKYLATION - This invention relates to an alkylation catalyst, a method for preparing the alkylation catalyst, and a method for alkylating olefins and paraffins. The alkylation catalyst includes a foam catalyst support wherein active catalyst particles have been appended to the surface of the foam support. | 2009-11-05 |
20090275792 | Dehydrogenation process with water control - The activity of a dehydrogenation catalyst is improved by increasing the water concentration maintained in the reactants toward the start of the catalyst's life, but after the catalyst has deactivated to the extent that the temperature required to maintain the conversion per pass of paraffinic hydrocarbon through the reaction zone increases by at least 2° C. | 2009-11-05 |
20090275793 | BRACHYTHERAPY DEVICES AND RELATED METHODS AND COMPUTER PROGRAM PRODUCTS - Methods of forming a low-dose-rate (LDR) brachytherapy device include depositing a solution comprising a soluble form of a radioactive material on a substrate. A water-insoluble form of the radioactive material is formed on the substrate by chemical precipitation and/or thermal decomposition. | 2009-11-05 |
20090275794 | Portable Electronic Sound, Physioacoustic, and Colored Light Therapy System - The present invention is a portable integrated sound, physioacoustic, and colored light apparatus. This is a self-contained electrically powered device designed to stimulate and facilitate the human body's innate self-healing mechanisms. The active components are housed in a portable pyramidal-shaped lower enclosure ( | 2009-11-05 |
20090275795 | CONTINENT OSTOMY SYSTEM WITH CHEMICAL NEUROMUSCULAR CONTROL - An apparatus for providing continence to a gastrointestinal ostomy of a patient, wherein the apparatus includes a lumen sealing device, a chemical neuromuscular control agent, and a mechanism for controlled, localized delivery of the neuromuscular control agent. The lumen sealing device is positioned in contact with the mucosal wall of the intestine and the neuromuscular control agent is delivered to the intestine via the mechanism for controlled, localized delivery, such that the neuromuscular control agent provides an inhibitory effect on peristalsis or smooth muscle contraction and relaxation cycles in the intestine to thereby arrest the advancement of the contents of the intestine. | 2009-11-05 |
20090275797 | HYBRID LAPAROSCOPIC-ENDOSCOPIC SURGICAL TECHNIQUE FOR DELIVERING END EFFECTORS THROUGH A NATURAL ORIFICE - A method for performing a hybrid laparoscopic-endoscopic procedure is achieved by inserting a medical instrument laparoscopically through an abdominal wall and into a gastric cavity, inserting an overtube and endoscope transorally into the gastric cavity to provide an access path to the gastric cavity, passing an end effector transorally to the surgical site translumenally within the endoscope, and attaching the end effector to a distal end of the medical instrument while the instrument is positioned within the gastric cavity. | 2009-11-05 |
20090275798 | OVERTUBE AND ENDOSCOPE SYSTEM SUITABLE FOR TREATMENT SUCH AS SUBMUCOSAL DISSECTION - An overtube includes: an endoscope insertion portion passing hole through which an insertion portion of an endoscope is passed; and at least one manipulator passing hole through which a manipulator insertion portion of a manipulator apparatus is passed. The manipulator insertion portion includes a driving portion which has at least one first joint and one second joint rotating clockwise and counterclockwise. The endoscope insertion portion passing hole includes an endoscope protrusion amount determination portion which determines a length of a protrusion of the endoscope; and an observation optical system observation direction determination portion which determines an observation direction of the endoscope. The manipulator passing hole includes a manipulator protrusion amount determination portion which determines positions of the first joint of the manipulator within the observation optical system; and a joint driving direction determination portion which determines rotating directions of shafts of joints within the observation direction. | 2009-11-05 |
20090275799 | AXIAL VISUALIZATION SYSTEMS - Axial visualization systems which utilize axially aligned imaging instruments for visualizing through an imaging hood purged of blood via a transparent fluid are described where an imaging element extending from a support shaft may be aligned within a working lumen defined through a deployment catheter. The imaging element may be positioned distal to the hood in its collapsed state and within the hood in its expanded state. The imaging element may be configured to seat itself securely within the catheter or to angle itself to adjust the viewing angle. Additionally, a disposable visualization sheath having a transparent lens may also be utilized to house an imaging instrument therein. | 2009-11-05 |
20090275800 | CAMERA FOR POSITIONING IN THE PYLORUS DURING BARIATRIC PROCEDURES - A lumenal camera assembly includes housing and a pill cam supports the housing. The housing is shaped and dimensioned for placement within the pylorus. | 2009-11-05 |
20090275801 | LIVING BODY OBSERVATION SYSTEM AND METHOD OF DRIVING LIVING BODY OBSERVATION SYSTEM - A living body observation system of the invention includes a living body information acquiring apparatus including: a living body information acquiring section; a wireless transmission section; a power source section for supplying driving power for driving the living body information acquiring section and the wireless transmission section; a magnetic field detecting section for outputting a detection result of a magnetic field from outside as an electric signal; and a power supply control section for controlling a supplying state of the driving power based on the electric signal, a magnetic field generating coil, a driving circuit for outputting a drive signal to the magnetic field generating coil, a switch for switching a generation state of a magnetic field, and a timer for outputting a signal for stopping output of the drive signal when a predetermined period has passed following switching from off to on of the switch. | 2009-11-05 |
20090275802 | Distally Expandable Dilation Tube - A transitional dilator including: a dilator body having a proximal end and a distal end, wherein the dilator body defines a sleeve orifice configured to receive an implant placement tube; and a round tip formed on the distal end of the dilator body, wherein the round tip defines a converging orifice terminating at an exit orifice configured to closely mate with a serial dilator; in which the round tip including a converging orifice further includes a wall split configured to receive the implant placement tube and expand to accommodate passage of the implant placement tube through the exit orifice. | 2009-11-05 |
20090275803 | ARTICULATION MECHANISM FOR A VAGINAL SPECULUM - An articulation mechanism for a vaginal speculum enables selective relative movement between an upper blade member and a lower blade member to affect vertical and angular spacing. The mechanism selectively enables quiet or clicking articulation according to at least one version. | 2009-11-05 |
20090275804 | Hinged Retractor With Sheath - A hinged retractor includes a distal portion adapted to be located inside the body of a patient during a surgical procedure and a proximal portion adapted to be closer to the surgeon during a surgical procedure. The hinged retractor includes a first side including a first blade and a second side including a second blade. The second side is joined to the first side proximate to a distal end of the hinged retractor. The hinged retractor includes a pivot proximate to the distal end. The hinged retractor is movable between a closed position and an open position, wherein a distance between a proximal portion of the first and second blades increases more than a distance between a distal portion of the first and second blades when the hinged retractor is moved from the closed position to the open position. | 2009-11-05 |
20090275805 | ON DEMAND HELP/IN-SERVICE FOR A MEDICAL DEVICE - The invention is a medical monitor including an electronic circuit configured to receive a signal from the physiological sensor. A microcomputer configured to process the signal from the physiological sensor generates a value representative of the physiological parameter. The microcomputer is also configured to cause the medical monitor to display an in-service help screen on a display on the medical monitor in response to a detection of a predetermined number of out of range values of the physiological parameter. The microcomputer can also be configured to process a second signal from a second sensor representative of a second parameter and the microcomputer configured to cause the medical monitor to display an in-service help screen on a display on the medical monitor in response to a detection of a predetermined number of out of range values of the second parameter. | 2009-11-05 |
20090275806 | Protable biomedical detective device - The present invention relates to a portable biomedical detective device comprising a carrier, a detective unit disposed in the carrier, an operating unit for converting biomedical signals of the detection into digitalized results, a display unit shown the digitalized results, and a power supply to drive the detective unit, the operating unit and the display unit. Therefore, biomedical signals on a biomedical cassette can be detected and converted into digital results by the portable biomedical detective device, which is light for carrying easily. | 2009-11-05 |
20090275807 | METHOD FOR MANAGING ALARMS IN A PHYSIOLOGICAL MONITORING SYSTEM - A method for managing alarm events in a physiological monitoring system is described. The method includes validating the accuracy of alarm events by checking if the alarm events are noise events. The method further includes identifying a pattern in alarm sequence or an alarm rate of at least one alarm type associated with the alarm events. The alarm rate is the frequency of the occurrence of alarm events for the particular alarm type. Based on the identified pattern in the alarm sequence and the alarm rate and patient data, an alarm level associated with the alarm type is adjusted. The hospital staff is notified depending on the criticality of the adjusted alarm level. Further, the alarm signals are suppressed when either a patient intervention or a pause signal is detected by the physiological monitoring system. | 2009-11-05 |
20090275808 | INTEGRATED PATIENT BED SYSTEM - The present invention includes an integrated system and methods for patient treatment, the system includes a hospital bed; a plurality of patient diagnostic and treatment devices connected to a network, wherein each of the devices can communicate to a network and exchange information with the network about the care of a patient; and a processor accessible adjacent to the bed and connected to the network to integrate information obtained from the devices through the network with one or more additional sources of information databases, wherein the processor can communicate to one or more patient treatment devices either directly or via the network and the processor directs the one or more patient treatment devices to change the treatment of the patient. | 2009-11-05 |